ClearNote Health
ClearNote Health (formerly Bluestar Genomics) is a US cancer detection company with offices in San Diego and San Mateo, California. Its proprietary 5hmC epigenomic platform combines cell-free DNA sequencing from a standard blood draw with machine learning to identify DNA-based alterations as cancer develops. The company commercializes Avantect, a suite of early-detection liquid biopsy tests for pancreatic and ovarian cancer that clinicians order through its laboratory, and Virtuoso, a research-use-only epigenomics platform sold to biopharma for drug discovery, therapy response and resistance research. ClearNote Health publishes no public developer program, API, SDK, or machine-readable specification: the clinician ordering path is a hosted intake form, and its public GitHub organization contains only forks of open-source bioinformatics tooling.
ClearNote Health is profiled on the APIs.io network. Tagged areas include Company, Health, Biotechnology, Genomics, and Epigenomics.
ClearNote Health’s developer surface includes engineering blog, support, and 9 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 5
The organization behind the API